Skip Navigation

A Phase I-A Study Evaluating the Safety, Tolerability and Preliminary Efficacy of IBI322 In Subjects with Advanced Malignant Tumors

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT04338659

Study #:
STUDY00147043

Start Date:
Dec 06, 2021

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04338659

View Complete Trial Details & Eligibility at ClinicalTrials.gov